June 21, 2026

Chemotherapy and Targeted Therapy

Retatrutide’s Triple-Threat: Eli Lilly’s New Clinical Data Redefines the Obesity Treatment Paradigm retatrutides-triple-threat-eli-lillys-new-clinical-data-redefines-the-obesity-treatment-paradigm

Retatrutide’s Triple-Threat: Eli Lilly’s New Clinical Data Redefines the Obesity Treatment Paradigm

Muslim June 21, 2026
In the rapidly evolving landscape of metabolic medicine, Eli Lilly has achieved a decisive breakthrough that positions...
Read More Read more about Retatrutide’s Triple-Threat: Eli Lilly’s New Clinical Data Redefines the Obesity Treatment Paradigm
Shifting the Paradigm: How ADME-One is Moving Human PK Projections to the Start of the Drug Discovery Funnel shifting-the-paradigm-how-adme-one-is-moving-human-pk-projections-to-the-start-of-the-drug-discovery-funnel

Shifting the Paradigm: How ADME-One is Moving Human PK Projections to the Start of the Drug Discovery Funnel

Asep Darmawan June 21, 2026
In the traditional landscape of small-molecule drug discovery, the timeline is often dictated by a rigid, linear...
Read More Read more about Shifting the Paradigm: How ADME-One is Moving Human PK Projections to the Start of the Drug Discovery Funnel
Bridging the Gap: Bionews Unveils “The Rare Journey,” an Immersive Digital Leap for the Rare Disease Community bridging-the-gap-bionews-unveils-the-rare-journey-an-immersive-digital-leap-for-the-rare-disease-community

Bridging the Gap: Bionews Unveils “The Rare Journey,” an Immersive Digital Leap for the Rare Disease Community

Nana Muazin June 20, 2026
PENSACOLA, Florida — August 19, 2024 — For millions of individuals worldwide, the diagnosis of a rare...
Read More Read more about Bridging the Gap: Bionews Unveils “The Rare Journey,” an Immersive Digital Leap for the Rare Disease Community
The FDA’s Commissioner’s National Priority Voucher: A Seismic Shift or Regulatory Turbulence? the-fdas-commissioners-national-priority-voucher-a-seismic-shift-or-regulatory-turbulence

The FDA’s Commissioner’s National Priority Voucher: A Seismic Shift or Regulatory Turbulence?

Basiran June 20, 2026
The pharmaceutical landscape is currently navigating a period of unprecedented regulatory evolution. In June 2025, the U.S....
Read More Read more about The FDA’s Commissioner’s National Priority Voucher: A Seismic Shift or Regulatory Turbulence?
Biopharma Industry Update: Executive Transitions, Clinical Breakthroughs, and Regulatory Shifts biopharma-industry-update-executive-transitions-clinical-breakthroughs-and-regulatory-shifts

Biopharma Industry Update: Executive Transitions, Clinical Breakthroughs, and Regulatory Shifts

Reynand Wu June 19, 2026
The landscape of the pharmaceutical and biotechnology sectors remains in constant flux, defined by high-stakes executive maneuvers,...
Read More Read more about Biopharma Industry Update: Executive Transitions, Clinical Breakthroughs, and Regulatory Shifts
Jazz Pharmaceuticals and AbCellera Forge Strategic Alliance to Tackle Solid Tumors with Multispecific Antibodies jazz-pharmaceuticals-and-abcellera-forge-strategic-alliance-to-tackle-solid-tumors-with-multispecific-antibodies

Jazz Pharmaceuticals and AbCellera Forge Strategic Alliance to Tackle Solid Tumors with Multispecific Antibodies

Evan Lee Salim June 17, 2026
Executive Summary In a strategic move to bolster its oncology pipeline, Jazz Pharmaceuticals has announced a high-stakes...
Read More Read more about Jazz Pharmaceuticals and AbCellera Forge Strategic Alliance to Tackle Solid Tumors with Multispecific Antibodies

You may have missed

advancing-the-frontline-metavivors-2026-strategic-push-for-metastatic-breast-cancer-reform

Advancing the Frontline: METAvivor’s 2026 Strategic Push for Metastatic Breast Cancer Reform

Suro Senen June 21, 2026
pioneering-the-future-a-new-wave-of-research-grants-targets-metastatic-breast-cancer

Pioneering the Future: A New Wave of Research Grants Targets Metastatic Breast Cancer

Ali Ikhwan June 21, 2026
the-heros-path-unlocking-the-anatomy-and-philosophy-of-virasana

The Hero’s Path: Unlocking the Anatomy and Philosophy of Virasana

Suro Senen June 21, 2026
from-shelters-to-science-how-biotech-launch-is-democratizing-the-laboratory-1

From Shelters to Science: How Biotech Launch is Democratizing the Laboratory

Reynand Wu June 21, 2026